The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alvogene, Biogen, BMS, Eisai, Inflarx, Kane, Merck, Regeneron, Samsung Bioepis, Sandoz, Sanofi.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 89bio, Aurinia, Eyenovia, Janssen, Levicept, Lixa, Omega, Osteal , Pacira.

Biopharmas raising money in public or private financings, including: Cyclacel, Zai Lab.

The top 10 biopharma stock gainers and losers for the week.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adaptimmune, Akari, Evotec, Halozyme, Kaken, Numab, Peak, TFF.

New hires and promotions in the biopharma industry, including: Agomab, Cassava, Diakonos, Exevir, Medicus, Theras, Vera.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accord International Astrazeneca, Foxo Technologies, Getz Healthcare, Helius Medical, Histosonics, Igea Medical, Know Labs, Lunit, Surgibox.

New hires and promotions in the med-tech industry, including: Genedx, Sonivie.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Boston Scientific, Irhythm, Mursla, Nevro, Sequana, Vektor.